Author

Ngarangi C. Mason

Malaghan Institute of Medical ResearchORCID 0009-0002-5267-4712Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:multiome· 2 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Gavin F. PainteriD· 3 shared Olga Rose Palmer· 3 shared Sarah L. DraperiD· 3 shared Abby L. MartiniD· 2 shared Ian F. HermansiD· 2 shared Isabelle MontgomerieiD· 2 shared Joanna KuangiD· 2 shared Jordan James MinnelliD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Gavin F. PainterORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyProceedings of the National Academy of SciencesPeer-reviewedAug 26, 2026

Engineering antigenic breadth against SARS-CoV-2 by pairing divergent RBDs within a single mRNA immunogen

Isabelle Montgomerie, Rebecca E. McKenzie, Olga Rose Palmer…·Lisa M. Connor

This paper designs an mRNA vaccine with fused SARS-CoV-2 RBDs from different variants to elicit cross-reactive antibodies without extensive somatic hypermutation.

DOI 10.1073/pnas.2602574123

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintJun 15, 2026

Circular RNA vaccine performance is determined by RNA quality and epitranscriptomic tuning rather than innate activation

Abby L. Martin, Jessica Cotterell, Kaitlin H. Buick…·Lisa M. Connor

This study shows that circRNA vaccine performance depends on RNA quality and epitranscriptomic modifications rather than innate immune activation.

DOI 10.64898/2026.06.11.731499

mousemultiome

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 12, 2026

Optimization of a liver Trm cell-inducing mRNA vaccine by reduction of type I interferon response

Jordan James Minnell, Mitch Ganley, Ariane R. Lee…·Ian F. Hermans

This study optimizes an mRNA vaccine to enhance liver Trm cell induction by reducing type I interferon responses through improved manufacturing.

DOI 10.64898/2026.05.07.723643

mousemultiome

𝕏 PostBluesky